

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.71262534 |
| 2 | ribosome assembly (GO:0042255) | 4.31026875 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.23800846 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.18636788 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.18636788 |
| 6 | neutrophil activation involved in immune response (GO:0002283) | 3.79221523 |
| 7 | proteasome assembly (GO:0043248) | 3.73046602 |
| 8 | immunoglobulin mediated immune response (GO:0016064) | 3.70082400 |
| 9 | positive regulation of interferon-alpha production (GO:0032727) | 3.65510173 |
| 10 | ribosomal small subunit assembly (GO:0000028) | 3.45913538 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.45077088 |
| 12 | regulation of interferon-alpha production (GO:0032647) | 3.44848280 |
| 13 | cellular response to interferon-beta (GO:0035458) | 3.43096653 |
| 14 | B cell mediated immunity (GO:0019724) | 3.42620433 |
| 15 | NIK/NF-kappaB signaling (GO:0038061) | 3.37804348 |
| 16 | regulation of RIG-I signaling pathway (GO:0039535) | 3.30271472 |
| 17 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.22230982 |
| 18 | natural killer cell mediated immunity (GO:0002228) | 3.20696134 |
| 19 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.20696134 |
| 20 | modulation by symbiont of host immune response (GO:0052553) | 3.18316509 |
| 21 | positive regulation by symbiont of host defense response (GO:0052509) | 3.18316509 |
| 22 | modulation by symbiont of host defense response (GO:0052031) | 3.18316509 |
| 23 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.18316509 |
| 24 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.18316509 |
| 25 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.18316509 |
| 26 | response to interferon-beta (GO:0035456) | 3.17290837 |
| 27 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.14636277 |
| 28 | defense response to protozoan (GO:0042832) | 3.14318651 |
| 29 | telomere maintenance via recombination (GO:0000722) | 3.14081417 |
| 30 | myeloid dendritic cell activation (GO:0001773) | 3.14054061 |
| 31 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.10106443 |
| 32 | negative regulation of phagocytosis (GO:0050765) | 3.09826984 |
| 33 | cellular response to type I interferon (GO:0071357) | 3.09040784 |
| 34 | type I interferon signaling pathway (GO:0060337) | 3.09040784 |
| 35 | response to type I interferon (GO:0034340) | 3.07722004 |
| 36 | cellular response to exogenous dsRNA (GO:0071360) | 2.99765652 |
| 37 | cellular response to zinc ion (GO:0071294) | 2.98944721 |
| 38 | synapsis (GO:0007129) | 2.98865821 |
| 39 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.97821319 |
| 40 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.97821319 |
| 41 | isotype switching (GO:0045190) | 2.97821319 |
| 42 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.97093435 |
| 43 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.96254986 |
| 44 | response to peptidoglycan (GO:0032494) | 2.94079991 |
| 45 | positive regulation of antigen processing and presentation (GO:0002579) | 2.90099589 |
| 46 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.89800164 |
| 47 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.89535132 |
| 48 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.89013891 |
| 49 | neutrophil activation (GO:0042119) | 2.88346623 |
| 50 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.87079915 |
| 51 | positive regulation of B cell differentiation (GO:0045579) | 2.86773336 |
| 52 | DNA deamination (GO:0045006) | 2.86673763 |
| 53 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.85860656 |
| 54 | response to muramyl dipeptide (GO:0032495) | 2.85438819 |
| 55 | DNA strand elongation (GO:0022616) | 2.84415992 |
| 56 | CENP-A containing nucleosome assembly (GO:0034080) | 2.83513712 |
| 57 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.82367608 |
| 58 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.80688975 |
| 59 | mitotic G2 DNA damage checkpoint (GO:0007095) | 2.80421813 |
| 60 | mitotic recombination (GO:0006312) | 2.79803563 |
| 61 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.79463015 |
| 62 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.78970448 |
| 63 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.77671304 |
| 64 | DNA replication initiation (GO:0006270) | 2.76301847 |
| 65 | mitotic G2/M transition checkpoint (GO:0044818) | 2.76085261 |
| 66 | response to protozoan (GO:0001562) | 2.75649329 |
| 67 | myeloid dendritic cell differentiation (GO:0043011) | 2.73521682 |
| 68 | DNA double-strand break processing (GO:0000729) | 2.73290630 |
| 69 | rRNA modification (GO:0000154) | 2.73049897 |
| 70 | positive regulation of interferon-beta production (GO:0032728) | 2.72268679 |
| 71 | granulocyte activation (GO:0036230) | 2.72004063 |
| 72 | regulation of chronic inflammatory response (GO:0002676) | 2.71632205 |
| 73 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.69532478 |
| 74 | IMP biosynthetic process (GO:0006188) | 2.69249462 |
| 75 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.69013155 |
| 76 | purine nucleobase biosynthetic process (GO:0009113) | 2.68976190 |
| 77 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.68061586 |
| 78 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.68061586 |
| 79 | negative regulation of viral genome replication (GO:0045071) | 2.65933247 |
| 80 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.65684168 |
| 81 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.65099968 |
| 82 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.63860674 |
| 83 | negative regulation of ligase activity (GO:0051352) | 2.63860674 |
| 84 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.62291151 |
| 85 | chromatin remodeling at centromere (GO:0031055) | 2.62230429 |
| 86 | regulation of B cell differentiation (GO:0045577) | 2.60797138 |
| 87 | transcription from mitochondrial promoter (GO:0006390) | 2.60617876 |
| 88 | T cell migration (GO:0072678) | 2.60148052 |
| 89 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.59382058 |
| 90 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.58725752 |
| 91 | T-helper 1 type immune response (GO:0042088) | 2.58459516 |
| 92 | negative thymic T cell selection (GO:0045060) | 2.58060912 |
| 93 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.57593367 |
| 94 | kinetochore organization (GO:0051383) | 2.57593361 |
| 95 | regulation of antigen processing and presentation (GO:0002577) | 2.57348046 |
| 96 | response to interferon-alpha (GO:0035455) | 2.57070646 |
| 97 | negative regulation of interleukin-12 production (GO:0032695) | 2.55182008 |
| 98 | nuclear pore complex assembly (GO:0051292) | 2.52163577 |
| 99 | positive regulation of interleukin-12 production (GO:0032735) | 2.50574620 |
| 100 | leukocyte aggregation (GO:0070486) | 2.50158069 |
| 101 | somatic recombination of immunoglobulin gene segments (GO:0016447) | 2.49413973 |
| 102 | histone mRNA metabolic process (GO:0008334) | 2.47799673 |
| 103 | positive regulation of defense response to virus by host (GO:0002230) | 2.47082263 |
| 104 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.46615046 |
| 105 | negative T cell selection (GO:0043383) | 2.46267902 |
| 106 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.46201743 |
| 107 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.46134569 |
| 108 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.45258101 |
| 109 | positive regulation of interleukin-17 production (GO:0032740) | 2.45078821 |
| 110 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.44373788 |
| 111 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.44251535 |
| 112 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.44251535 |
| 113 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.44251535 |
| 114 | histone exchange (GO:0043486) | 2.43289107 |
| 115 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.43224723 |
| 116 | lymphocyte mediated immunity (GO:0002449) | 2.42584044 |
| 117 | leukocyte mediated cytotoxicity (GO:0001909) | 2.42448570 |
| 118 | interferon-gamma production (GO:0032609) | 2.41955010 |
| 119 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.41903473 |
| 120 | IMP metabolic process (GO:0046040) | 2.41833402 |
| 121 | formation of translation preinitiation complex (GO:0001731) | 2.41784880 |
| 122 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.41689523 |
| 123 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.41689523 |
| 124 | nuclear pore organization (GO:0006999) | 2.41427567 |
| 125 | myeloid cell activation involved in immune response (GO:0002275) | 2.41304817 |
| 126 | rRNA methylation (GO:0031167) | 2.40568919 |
| 127 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.40389755 |
| 128 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.39737927 |
| 129 | regulation of meiosis I (GO:0060631) | 2.38277707 |
| 130 | cellular response to dsRNA (GO:0071359) | 2.38079643 |
| 131 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.37601152 |
| 132 | dendritic cell chemotaxis (GO:0002407) | 2.37245585 |
| 133 | meiotic chromosome segregation (GO:0045132) | 2.37125752 |
| 134 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.36762112 |
| 135 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.36737929 |
| 136 | dendritic cell differentiation (GO:0097028) | 2.36304344 |
| 137 | positive regulation of isotype switching (GO:0045830) | 2.35731795 |
| 138 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.35150038 |
| 139 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.34990752 |
| 140 | macrophage activation involved in immune response (GO:0002281) | 2.34400652 |
| 141 | telomere maintenance via telomere lengthening (GO:0010833) | 2.34159090 |
| 142 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.33603064 |
| 143 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.33603064 |
| 144 | pseudouridine synthesis (GO:0001522) | 2.33524206 |
| 145 | positive regulation of ligase activity (GO:0051351) | 2.33043366 |
| 146 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.32906149 |
| 147 | regulation of activation of Janus kinase activity (GO:0010533) | 2.32763088 |
| 148 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.32620309 |
| 149 | mismatch repair (GO:0006298) | 2.32564630 |
| 150 | DNA replication checkpoint (GO:0000076) | 2.32220539 |
| 151 | somatic diversification of immunoglobulins (GO:0016445) | 2.32132768 |
| 152 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.30236398 |
| 153 | regulation of necroptotic process (GO:0060544) | 2.30052312 |
| 154 | telomere maintenance (GO:0000723) | 2.29449115 |
| 155 | B cell receptor signaling pathway (GO:0050853) | 2.28639460 |
| 156 | necroptotic process (GO:0070266) | 2.28329258 |
| 157 | mature B cell differentiation (GO:0002335) | 2.27870498 |
| 158 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.27842493 |
| 159 | regulation of gamma-delta T cell activation (GO:0046643) | 2.27569198 |
| 160 | mature B cell differentiation involved in immune response (GO:0002313) | 2.27534727 |
| 161 | respiratory burst (GO:0045730) | 2.27273233 |
| 162 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.27192628 |
| 163 | histone mRNA catabolic process (GO:0071044) | 2.27171079 |
| 164 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.26124289 |
| 165 | mitotic metaphase plate congression (GO:0007080) | 2.25886852 |
| 166 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.25786559 |
| 167 | response to X-ray (GO:0010165) | 2.25686963 |
| 168 | hepatocyte apoptotic process (GO:0097284) | 2.25200109 |
| 169 | nucleobase biosynthetic process (GO:0046112) | 2.24873396 |
| 170 | maturation of 5.8S rRNA (GO:0000460) | 2.24344177 |
| 171 | tryptophan metabolic process (GO:0006568) | 2.24088317 |
| 172 | B cell activation involved in immune response (GO:0002312) | 2.19800789 |
| 173 | DNA ligation (GO:0006266) | 2.19203994 |
| 174 | regulation of helicase activity (GO:0051095) | 2.18379292 |
| 175 | prenylation (GO:0097354) | 2.17671508 |
| 176 | protein prenylation (GO:0018342) | 2.17671508 |
| 177 | regulation of translational termination (GO:0006449) | 2.17326538 |
| 178 | mitochondrial RNA metabolic process (GO:0000959) | 2.17100082 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.03641378 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.74444284 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.15604051 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.70605778 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.14295963 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.11585143 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.87902021 |
| 8 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.86741051 |
| 9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.82146825 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.65366299 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.63884695 |
| 12 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.54704683 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.54235799 |
| 14 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.41207053 |
| 15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.37096386 |
| 16 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.36126606 |
| 17 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.32147410 |
| 18 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.30541718 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.29978290 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.25207037 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.17984522 |
| 22 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.16686413 |
| 23 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.11246261 |
| 24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.08275804 |
| 25 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.01740617 |
| 26 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.98128683 |
| 27 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.95273223 |
| 28 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.87793404 |
| 29 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.81005832 |
| 30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.80804941 |
| 31 | MYB_26560356_Chip-Seq_TH2_Human | 1.80527503 |
| 32 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.79377374 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.78469805 |
| 34 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.77816188 |
| 35 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.76705299 |
| 36 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73847198 |
| 37 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.72278985 |
| 38 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.69856169 |
| 39 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69781467 |
| 40 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61402325 |
| 41 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.61271109 |
| 42 | MYB_26560356_Chip-Seq_TH1_Human | 1.61095192 |
| 43 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.59024966 |
| 44 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.58904642 |
| 45 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.57528793 |
| 46 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.55871502 |
| 47 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.54125974 |
| 48 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.53600920 |
| 49 | MAF_26560356_Chip-Seq_TH1_Human | 1.53032123 |
| 50 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.51494362 |
| 51 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.49065552 |
| 52 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.48934572 |
| 53 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.45920447 |
| 54 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.42721256 |
| 55 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.41829156 |
| 56 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.41321987 |
| 57 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.38819077 |
| 58 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.38285023 |
| 59 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.38199034 |
| 60 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.37708825 |
| 61 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.36967448 |
| 62 | MYC_22102868_ChIP-Seq_BL_Human | 1.36695019 |
| 63 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.35668000 |
| 64 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.35342779 |
| 65 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.35094278 |
| 66 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.33270326 |
| 67 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.30170936 |
| 68 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.29026801 |
| 69 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27036312 |
| 70 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.25925362 |
| 71 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.25795113 |
| 72 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.21404504 |
| 73 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.20982836 |
| 74 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.20393754 |
| 75 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.19588197 |
| 76 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.18920811 |
| 77 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.18642740 |
| 78 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.17623969 |
| 79 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16384311 |
| 80 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.15071750 |
| 81 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.14906382 |
| 82 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14753096 |
| 83 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.14376929 |
| 84 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.12538420 |
| 85 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.11973164 |
| 86 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.11136711 |
| 87 | UTX_26944678_Chip-Seq_JUKART_Human | 1.10618850 |
| 88 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.09281803 |
| 89 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.07856897 |
| 90 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.07691960 |
| 91 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.07124942 |
| 92 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.06416793 |
| 93 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.06002762 |
| 94 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05699786 |
| 95 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05445265 |
| 96 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05193160 |
| 97 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03833518 |
| 98 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.03278539 |
| 99 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.02098766 |
| 100 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.00431621 |
| 101 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.99809896 |
| 102 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.99619243 |
| 103 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.99499730 |
| 104 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.98927208 |
| 105 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.97759739 |
| 106 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.97677817 |
| 107 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.95240969 |
| 108 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.94699921 |
| 109 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.94662107 |
| 110 | MAF_26560356_Chip-Seq_TH2_Human | 0.94113535 |
| 111 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.93982378 |
| 112 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.93043021 |
| 113 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.92418536 |
| 114 | GATA3_26560356_Chip-Seq_TH2_Human | 0.90796124 |
| 115 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.90662352 |
| 116 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90134277 |
| 117 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.90066568 |
| 118 | EWS_26573619_Chip-Seq_HEK293_Human | 0.89590962 |
| 119 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88696037 |
| 120 | SPI1_23127762_ChIP-Seq_K562_Human | 0.87619134 |
| 121 | VDR_22108803_ChIP-Seq_LS180_Human | 0.87433952 |
| 122 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86111422 |
| 123 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85992829 |
| 124 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.85103624 |
| 125 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.84454006 |
| 126 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.84236644 |
| 127 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.81141465 |
| 128 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.80511931 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.51704238 |
| 2 | MP0000685_abnormal_immune_system | 3.17055753 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 3.15978016 |
| 4 | MP0009785_altered_susceptibility_to | 2.97591434 |
| 5 | MP0005671_abnormal_response_to | 2.93194605 |
| 6 | MP0002396_abnormal_hematopoietic_system | 2.82415638 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 2.76045489 |
| 8 | MP0003436_decreased_susceptibility_to | 2.69167464 |
| 9 | MP0001800_abnormal_humoral_immune | 2.58925377 |
| 10 | MP0005387_immune_system_phenotype | 2.57725016 |
| 11 | MP0001790_abnormal_immune_system | 2.57725016 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.51921959 |
| 13 | MP0005025_abnormal_response_to | 2.50379905 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.46335833 |
| 15 | MP0002166_altered_tumor_susceptibility | 2.43486786 |
| 16 | MP0003763_abnormal_thymus_physiology | 2.36629567 |
| 17 | MP0002723_abnormal_immune_serum | 2.34706962 |
| 18 | MP0002419_abnormal_innate_immunity | 2.32337407 |
| 19 | MP0001819_abnormal_immune_cell | 2.26889792 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.26023425 |
| 21 | MP0003693_abnormal_embryo_hatching | 2.18025634 |
| 22 | MP0002006_tumorigenesis | 2.15924504 |
| 23 | MP0002398_abnormal_bone_marrow | 2.12883068 |
| 24 | MP0010094_abnormal_chromosome_stability | 2.05744471 |
| 25 | MP0001853_heart_inflammation | 2.01850061 |
| 26 | MP0006082_CNS_inflammation | 1.94145403 |
| 27 | MP0000716_abnormal_immune_system | 1.88858122 |
| 28 | MP0003111_abnormal_nucleus_morphology | 1.83233348 |
| 29 | MP0008057_abnormal_DNA_replication | 1.82677522 |
| 30 | MP0003786_premature_aging | 1.82230002 |
| 31 | MP0003077_abnormal_cell_cycle | 1.81382253 |
| 32 | MP0000689_abnormal_spleen_morphology | 1.80404324 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.79566490 |
| 34 | MP0005464_abnormal_platelet_physiology | 1.78238198 |
| 35 | MP0002405_respiratory_system_inflammati | 1.76805922 |
| 36 | MP0001545_abnormal_hematopoietic_system | 1.72478687 |
| 37 | MP0005397_hematopoietic_system_phenotyp | 1.72478687 |
| 38 | MP0002722_abnormal_immune_system | 1.72417780 |
| 39 | MP0003724_increased_susceptibility_to | 1.68543649 |
| 40 | MP0002429_abnormal_blood_cell | 1.67738033 |
| 41 | MP0004808_abnormal_hematopoietic_stem | 1.66718057 |
| 42 | MP0000490_abnormal_crypts_of | 1.64159986 |
| 43 | MP0008007_abnormal_cellular_replicative | 1.60059048 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.57172175 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.51983350 |
| 46 | MP0003941_abnormal_skin_development | 1.49458708 |
| 47 | MP0004510_myositis | 1.48691034 |
| 48 | MP0005058_abnormal_lysosome_morphology | 1.46238111 |
| 49 | MP0005174_abnormal_tail_pigmentation | 1.45773849 |
| 50 | MP0010307_abnormal_tumor_latency | 1.44028486 |
| 51 | MP0003718_maternal_effect | 1.43785902 |
| 52 | MP0004957_abnormal_blastocyst_morpholog | 1.41319467 |
| 53 | MP0008058_abnormal_DNA_repair | 1.35979950 |
| 54 | MP0000703_abnormal_thymus_morphology | 1.35399471 |
| 55 | MP0008877_abnormal_DNA_methylation | 1.29260200 |
| 56 | MP0003186_abnormal_redox_activity | 1.28133756 |
| 57 | MP0004947_skin_inflammation | 1.27957278 |
| 58 | MP0008469_abnormal_protein_level | 1.26791246 |
| 59 | MP0001873_stomach_inflammation | 1.26272490 |
| 60 | MP0002163_abnormal_gland_morphology | 1.25819690 |
| 61 | MP0005310_abnormal_salivary_gland | 1.25291215 |
| 62 | MP0000858_altered_metastatic_potential | 1.23931063 |
| 63 | MP0003950_abnormal_plasma_membrane | 1.23042025 |
| 64 | MP0010352_gastrointestinal_tract_polyps | 1.21403662 |
| 65 | MP0006036_abnormal_mitochondrial_physio | 1.20739714 |
| 66 | MP0000015_abnormal_ear_pigmentation | 1.20160737 |
| 67 | MP0001661_extended_life_span | 1.20122724 |
| 68 | MP0003303_peritoneal_inflammation | 1.19078511 |
| 69 | MP0001533_abnormal_skeleton_physiology | 1.17169838 |
| 70 | MP0003448_altered_tumor_morphology | 1.09852180 |
| 71 | MP0002019_abnormal_tumor_incidence | 1.09337735 |
| 72 | MP0003656_abnormal_erythrocyte_physiolo | 1.08934529 |
| 73 | MP0008260_abnormal_autophagy | 1.08812253 |
| 74 | MP0009764_decreased_sensitivity_to | 1.08401935 |
| 75 | MP0006035_abnormal_mitochondrial_morpho | 1.08224127 |
| 76 | MP0002009_preneoplasia | 1.06794957 |
| 77 | MP0002877_abnormal_melanocyte_morpholog | 1.06009996 |
| 78 | MP0000372_irregular_coat_pigmentation | 1.01427296 |
| 79 | MP0000343_altered_response_to | 1.01303799 |
| 80 | MP0002095_abnormal_skin_pigmentation | 1.01209940 |
| 81 | MP0002138_abnormal_hepatobiliary_system | 0.99473526 |
| 82 | MP0002132_abnormal_respiratory_system | 0.98937609 |
| 83 | MP0005167_abnormal_blood-brain_barrier | 0.97707234 |
| 84 | MP0000358_abnormal_cell_content/ | 0.96961848 |
| 85 | MP0000465_gastrointestinal_hemorrhage | 0.95526679 |
| 86 | MP0005075_abnormal_melanosome_morpholog | 0.93958760 |
| 87 | MP0006054_spinal_hemorrhage | 0.93035830 |
| 88 | MP0001348_abnormal_lacrimal_gland | 0.93018023 |
| 89 | MP0003172_abnormal_lysosome_physiology | 0.90366388 |
| 90 | MP0002254_reproductive_system_inflammat | 0.89992276 |
| 91 | MP0000313_abnormal_cell_death | 0.89804195 |
| 92 | MP0008004_abnormal_stomach_pH | 0.86186483 |
| 93 | MP0004084_abnormal_cardiac_muscle | 0.85861125 |
| 94 | MP0009763_increased_sensitivity_to | 0.81908110 |
| 95 | MP0004782_abnormal_surfactant_physiolog | 0.80803285 |
| 96 | MP0001191_abnormal_skin_condition | 0.80431297 |
| 97 | MP0002837_dystrophic_cardiac_calcinosis | 0.79988609 |
| 98 | MP0005451_abnormal_body_composition | 0.79444921 |
| 99 | MP0002933_joint_inflammation | 0.79172222 |
| 100 | MP0005165_increased_susceptibility_to | 0.79055632 |
| 101 | MP0000569_abnormal_digit_pigmentation | 0.78819220 |
| 102 | MP0001730_embryonic_growth_arrest | 0.78499467 |
| 103 | MP0003195_calcinosis | 0.78341590 |
| 104 | MP0003943_abnormal_hepatobiliary_system | 0.77809430 |
| 105 | MP0003828_pulmonary_edema | 0.76877310 |
| 106 | MP0005410_abnormal_fertilization | 0.76173724 |
| 107 | MP0003252_abnormal_bile_duct | 0.76029919 |
| 108 | MP0002277_abnormal_respiratory_mucosa | 0.75385128 |
| 109 | MP0000350_abnormal_cell_proliferation | 0.74749168 |
| 110 | MP0010678_abnormal_skin_adnexa | 0.74294847 |
| 111 | MP0008873_increased_physiological_sensi | 0.73529440 |
| 112 | MP0003866_abnormal_defecation | 0.73014770 |
| 113 | MP0004215_abnormal_myocardial_fiber | 0.71896630 |
| 114 | MP0001346_abnormal_lacrimal_gland | 0.71852266 |
| 115 | MP0009278_abnormal_bone_marrow | 0.71307532 |
| 116 | MP0003566_abnormal_cell_adhesion | 0.67625431 |
| 117 | MP0009840_abnormal_foam_cell | 0.66418695 |
| 118 | MP0005023_abnormal_wound_healing | 0.66100436 |
| 119 | MP0009697_abnormal_copulation | 0.63359423 |
| 120 | MP0003191_abnormal_cellular_cholesterol | 0.61566255 |
| 121 | MP0004147_increased_porphyrin_level | 0.58938447 |
| 122 | MP0000371_diluted_coat_color | 0.56716291 |
| 123 | MP0008932_abnormal_embryonic_tissue | 0.56652443 |
| 124 | MP0000767_abnormal_smooth_muscle | 0.56325919 |
| 125 | MP0000598_abnormal_liver_morphology | 0.55394374 |
| 126 | MP0005076_abnormal_cell_differentiation | 0.55001068 |
| 127 | MP0005390_skeleton_phenotype | 0.54967344 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.96888695 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.68378520 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.30806123 |
| 4 | Myositis (HP:0100614) | 4.29588399 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.19233473 |
| 6 | Autoimmune thrombocytopenia (HP:0001973) | 3.96927394 |
| 7 | Recurrent viral infections (HP:0004429) | 3.62708304 |
| 8 | Birth length less than 3rd percentile (HP:0003561) | 3.56808273 |
| 9 | Thrombocytosis (HP:0001894) | 3.52908110 |
| 10 | Recurrent fungal infections (HP:0002841) | 3.51867170 |
| 11 | Chronic otitis media (HP:0000389) | 3.42682891 |
| 12 | Optic neuritis (HP:0100653) | 3.31674540 |
| 13 | Retrobulbar optic neuritis (HP:0100654) | 3.31674540 |
| 14 | IgM deficiency (HP:0002850) | 3.23446686 |
| 15 | Increased IgM level (HP:0003496) | 3.20657268 |
| 16 | Recurrent skin infections (HP:0001581) | 3.14389839 |
| 17 | Orchitis (HP:0100796) | 3.13162811 |
| 18 | Recurrent bronchitis (HP:0002837) | 3.11138259 |
| 19 | Mediastinal lymphadenopathy (HP:0100721) | 3.07339342 |
| 20 | Abnormality of macrophages (HP:0004311) | 3.06489463 |
| 21 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.05682993 |
| 22 | Abnormality of T cell number (HP:0011839) | 2.90513277 |
| 23 | Petechiae (HP:0000967) | 2.88255959 |
| 24 | Vasculitis (HP:0002633) | 2.87384969 |
| 25 | Abnormality of T cell physiology (HP:0011840) | 2.86482223 |
| 26 | Autoimmune hemolytic anemia (HP:0001890) | 2.79714113 |
| 27 | Periodontitis (HP:0000704) | 2.79483731 |
| 28 | Abnormality of T cells (HP:0002843) | 2.78097567 |
| 29 | Chromsome breakage (HP:0040012) | 2.75703622 |
| 30 | Eosinophilia (HP:0001880) | 2.75604637 |
| 31 | Abnormality of methionine metabolism (HP:0010901) | 2.74674588 |
| 32 | IgG deficiency (HP:0004315) | 2.73209821 |
| 33 | Granulocytopenia (HP:0001913) | 2.71217221 |
| 34 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.66950613 |
| 35 | Recurrent cutaneous fungal infections (HP:0011370) | 2.66950613 |
| 36 | Type I transferrin isoform profile (HP:0003642) | 2.66865107 |
| 37 | Meningitis (HP:0001287) | 2.65299433 |
| 38 | Cellulitis (HP:0100658) | 2.59160649 |
| 39 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.58387044 |
| 40 | Keratoconjunctivitis sicca (HP:0001097) | 2.57175132 |
| 41 | Reticulocytopenia (HP:0001896) | 2.57048871 |
| 42 | Agammaglobulinemia (HP:0004432) | 2.54699083 |
| 43 | Thyroiditis (HP:0100646) | 2.54226637 |
| 44 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.53286855 |
| 45 | Hypergammaglobulinemia (HP:0010702) | 2.52489788 |
| 46 | Increased hepatocellular lipid droplets (HP:0006565) | 2.50577653 |
| 47 | Leukocytosis (HP:0001974) | 2.50408203 |
| 48 | Obstructive lung disease (HP:0006536) | 2.50115482 |
| 49 | Chronic obstructive pulmonary disease (HP:0006510) | 2.50115482 |
| 50 | Pustule (HP:0200039) | 2.48257549 |
| 51 | T lymphocytopenia (HP:0005403) | 2.47960389 |
| 52 | Rhabdomyosarcoma (HP:0002859) | 2.47197546 |
| 53 | Keratoconjunctivitis (HP:0001096) | 2.46128320 |
| 54 | Abnormal number of erythroid precursors (HP:0012131) | 2.44290951 |
| 55 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.42662720 |
| 56 | Hematochezia (HP:0002573) | 2.41005752 |
| 57 | Abnormality of eosinophils (HP:0001879) | 2.39968387 |
| 58 | Abnormality of the prostate (HP:0008775) | 2.38618710 |
| 59 | Panhypogammaglobulinemia (HP:0003139) | 2.37131141 |
| 60 | Increased CSF lactate (HP:0002490) | 2.36678560 |
| 61 | Prostate neoplasm (HP:0100787) | 2.35536197 |
| 62 | IgA deficiency (HP:0002720) | 2.35219494 |
| 63 | Lipid accumulation in hepatocytes (HP:0006561) | 2.35188376 |
| 64 | Abnormal spermatogenesis (HP:0008669) | 2.35164282 |
| 65 | Clubbing of toes (HP:0100760) | 2.34059157 |
| 66 | Recurrent pneumonia (HP:0006532) | 2.33875952 |
| 67 | Amaurosis fugax (HP:0100576) | 2.32644927 |
| 68 | Combined immunodeficiency (HP:0005387) | 2.31938477 |
| 69 | Exertional dyspnea (HP:0002875) | 2.30761464 |
| 70 | Severe combined immunodeficiency (HP:0004430) | 2.30607120 |
| 71 | Encephalitis (HP:0002383) | 2.30450453 |
| 72 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.30388449 |
| 73 | Spontaneous hematomas (HP:0007420) | 2.27594640 |
| 74 | Abnormal protein glycosylation (HP:0012346) | 2.27529209 |
| 75 | Abnormal glycosylation (HP:0012345) | 2.27529209 |
| 76 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.27529209 |
| 77 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.27529209 |
| 78 | B lymphocytopenia (HP:0010976) | 2.26800905 |
| 79 | Abnormality of B cell number (HP:0010975) | 2.26800905 |
| 80 | Poor head control (HP:0002421) | 2.25375121 |
| 81 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.25228465 |
| 82 | Abnormality of chromosome stability (HP:0003220) | 2.25183025 |
| 83 | Myelodysplasia (HP:0002863) | 2.24964510 |
| 84 | Lymphoma (HP:0002665) | 2.22660139 |
| 85 | Prolonged bleeding time (HP:0003010) | 2.22644652 |
| 86 | Oral leukoplakia (HP:0002745) | 2.22417470 |
| 87 | Basal ganglia calcification (HP:0002135) | 2.21386810 |
| 88 | Arterial thrombosis (HP:0004420) | 2.18740384 |
| 89 | Osteomyelitis (HP:0002754) | 2.18651463 |
| 90 | Gingivitis (HP:0000230) | 2.18240144 |
| 91 | Leukopenia (HP:0001882) | 2.13748651 |
| 92 | Aplastic anemia (HP:0001915) | 2.13587034 |
| 93 | Pulmonary fibrosis (HP:0002206) | 2.13585642 |
| 94 | Reduced antithrombin III activity (HP:0001976) | 2.11482300 |
| 95 | Lymphopenia (HP:0001888) | 2.10953840 |
| 96 | Urticaria (HP:0001025) | 2.10855396 |
| 97 | Stomatitis (HP:0010280) | 2.10449788 |
| 98 | Epistaxis (HP:0000421) | 2.10404441 |
| 99 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.10095923 |
| 100 | Recurrent lower respiratory tract infections (HP:0002783) | 2.09703443 |
| 101 | Syringomyelia (HP:0003396) | 2.09592316 |
| 102 | Spinal cord lesions (HP:0100561) | 2.09592316 |
| 103 | Abnormality of the preputium (HP:0100587) | 2.07527404 |
| 104 | Neutropenia (HP:0001875) | 2.07500649 |
| 105 | Mitochondrial inheritance (HP:0001427) | 2.06527295 |
| 106 | Acute necrotizing encephalopathy (HP:0006965) | 2.06301993 |
| 107 | Degeneration of anterior horn cells (HP:0002398) | 2.06119547 |
| 108 | Abnormality of the anterior horn cell (HP:0006802) | 2.06119547 |
| 109 | Biliary tract neoplasm (HP:0100574) | 2.05798219 |
| 110 | Chronic diarrhea (HP:0002028) | 2.05177243 |
| 111 | Pulmonary infiltrates (HP:0002113) | 2.04881437 |
| 112 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.04506372 |
| 113 | Osteolytic defects of the hand bones (HP:0009699) | 2.04506372 |
| 114 | Meckel diverticulum (HP:0002245) | 2.04430582 |
| 115 | Volvulus (HP:0002580) | 2.02941360 |
| 116 | Abnormality of the fingertips (HP:0001211) | 2.02814004 |
| 117 | Duodenal stenosis (HP:0100867) | 2.01771391 |
| 118 | Small intestinal stenosis (HP:0012848) | 2.01771391 |
| 119 | Vacuolated lymphocytes (HP:0001922) | 2.01518593 |
| 120 | Agnosia (HP:0010524) | 1.98995445 |
| 121 | Nasal polyposis (HP:0100582) | 1.98978234 |
| 122 | Hypoplasia of the thymus (HP:0000778) | 1.98778264 |
| 123 | Entropion (HP:0000621) | 1.98756964 |
| 124 | Increased serum lactate (HP:0002151) | 1.98727813 |
| 125 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.96493813 |
| 126 | Abnormality of lateral ventricle (HP:0030047) | 1.95412662 |
| 127 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.93845178 |
| 128 | Abnormality of alanine metabolism (HP:0010916) | 1.93845178 |
| 129 | Hyperalaninemia (HP:0003348) | 1.93845178 |
| 130 | Abnormality of the ileum (HP:0001549) | 1.91252313 |
| 131 | Azoospermia (HP:0000027) | 1.89827660 |
| 132 | Progressive macrocephaly (HP:0004481) | 1.88615669 |
| 133 | Xerostomia (HP:0000217) | 1.86752801 |
| 134 | Renal Fanconi syndrome (HP:0001994) | 1.86151230 |
| 135 | Palpitations (HP:0001962) | 1.85457751 |
| 136 | Gangrene (HP:0100758) | 1.84843020 |
| 137 | Congenital, generalized hypertrichosis (HP:0004540) | 1.84817480 |
| 138 | Hypoproteinemia (HP:0003075) | 1.84336895 |
| 139 | Dyschromatopsia (HP:0007641) | 1.83155237 |
| 140 | Acute encephalopathy (HP:0006846) | 1.82733123 |
| 141 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.82588971 |
| 142 | Respiratory difficulties (HP:0002880) | 1.81917774 |
| 143 | Anorexia (HP:0002039) | 1.81644574 |
| 144 | Cutaneous melanoma (HP:0012056) | 1.78220383 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 3.26317948 |
| 2 | MAP4K1 | 3.11832863 |
| 3 | IRAK4 | 2.97359493 |
| 4 | TYK2 | 2.71406990 |
| 5 | TBK1 | 2.52262381 |
| 6 | IRAK3 | 2.32956871 |
| 7 | TXK | 2.29879815 |
| 8 | BUB1 | 2.23536613 |
| 9 | KIT | 2.22395299 |
| 10 | WEE1 | 2.19471518 |
| 11 | JAK3 | 2.15677129 |
| 12 | NME2 | 2.15058925 |
| 13 | IKBKE | 2.08050342 |
| 14 | IKBKB | 2.05346781 |
| 15 | EIF2AK1 | 1.92364002 |
| 16 | BLK | 1.78313766 |
| 17 | TRIM28 | 1.74002039 |
| 18 | CDC7 | 1.73260763 |
| 19 | TTK | 1.71526422 |
| 20 | RPS6KA4 | 1.71502517 |
| 21 | CSF1R | 1.70952178 |
| 22 | PIM2 | 1.69553485 |
| 23 | ZAP70 | 1.67603400 |
| 24 | NEK1 | 1.67410760 |
| 25 | BRSK2 | 1.63380408 |
| 26 | ACVR1B | 1.59021649 |
| 27 | BTK | 1.56940807 |
| 28 | VRK1 | 1.56701336 |
| 29 | STK10 | 1.54215583 |
| 30 | SYK | 1.50684127 |
| 31 | TEC | 1.50090583 |
| 32 | TLK1 | 1.48887253 |
| 33 | PIM1 | 1.42112489 |
| 34 | FLT3 | 1.41825149 |
| 35 | NEK2 | 1.41564855 |
| 36 | PIK3CG | 1.40144562 |
| 37 | TGFBR1 | 1.34605066 |
| 38 | STK16 | 1.33725579 |
| 39 | STK4 | 1.31412786 |
| 40 | CHUK | 1.30778102 |
| 41 | PLK4 | 1.29780309 |
| 42 | MKNK1 | 1.26863846 |
| 43 | VRK2 | 1.23280333 |
| 44 | ERBB3 | 1.23180175 |
| 45 | EIF2AK2 | 1.22262573 |
| 46 | JAK1 | 1.20870941 |
| 47 | SCYL2 | 1.14477024 |
| 48 | TGFBR2 | 1.14373690 |
| 49 | SRPK1 | 1.13167477 |
| 50 | ZAK | 1.12263976 |
| 51 | PDK2 | 1.11737691 |
| 52 | TAOK3 | 1.09580102 |
| 53 | SIK3 | 1.08784894 |
| 54 | PBK | 1.08396216 |
| 55 | MAP3K12 | 1.07205549 |
| 56 | CLK1 | 1.04190172 |
| 57 | MAPKAPK3 | 1.03231709 |
| 58 | ATR | 1.02626668 |
| 59 | KDR | 1.02066444 |
| 60 | MAP3K13 | 1.01899991 |
| 61 | MAP2K3 | 1.00327103 |
| 62 | LYN | 0.99905376 |
| 63 | LCK | 0.99824184 |
| 64 | STK24 | 0.96528576 |
| 65 | NLK | 0.95567675 |
| 66 | CDK4 | 0.91406522 |
| 67 | MST4 | 0.90382502 |
| 68 | RIPK4 | 0.88112408 |
| 69 | EIF2AK3 | 0.86382400 |
| 70 | NEK9 | 0.85048742 |
| 71 | NUAK1 | 0.84674774 |
| 72 | GRK7 | 0.82463608 |
| 73 | AURKB | 0.82258378 |
| 74 | MKNK2 | 0.79817021 |
| 75 | CDK6 | 0.77155556 |
| 76 | CSK | 0.76960033 |
| 77 | HCK | 0.76771475 |
| 78 | PLK1 | 0.75024063 |
| 79 | BRSK1 | 0.74709592 |
| 80 | CDK7 | 0.72482425 |
| 81 | BMPR2 | 0.70236787 |
| 82 | TRPM7 | 0.70025086 |
| 83 | FGR | 0.69574758 |
| 84 | CCNB1 | 0.67049194 |
| 85 | LRRK2 | 0.67041943 |
| 86 | ITK | 0.66838813 |
| 87 | RPS6KA5 | 0.65155774 |
| 88 | RPS6KB2 | 0.63976652 |
| 89 | PAK4 | 0.63595923 |
| 90 | FGFR3 | 0.63534505 |
| 91 | CDK8 | 0.63208038 |
| 92 | MST1R | 0.62133642 |
| 93 | MAP3K8 | 0.59322165 |
| 94 | BMPR1B | 0.59003788 |
| 95 | YES1 | 0.58329837 |
| 96 | FRK | 0.56601724 |
| 97 | TAF1 | 0.56551003 |
| 98 | PLK2 | 0.56237779 |
| 99 | MELK | 0.56104111 |
| 100 | DAPK1 | 0.55366299 |
| 101 | MATK | 0.53755537 |
| 102 | TESK2 | 0.52213448 |
| 103 | GRK6 | 0.51635221 |
| 104 | MAPKAPK2 | 0.51616385 |
| 105 | MAPK11 | 0.49695928 |
| 106 | DYRK3 | 0.49200464 |
| 107 | NME1 | 0.48988374 |
| 108 | MARK3 | 0.47506872 |
| 109 | BCR | 0.46388375 |
| 110 | IRAK1 | 0.46097044 |
| 111 | FGFR4 | 0.44794213 |
| 112 | JAK2 | 0.44515825 |
| 113 | ATM | 0.44035292 |
| 114 | MYLK | 0.44016867 |
| 115 | BCKDK | 0.43882296 |
| 116 | PASK | 0.43206576 |
| 117 | STK3 | 0.42692400 |
| 118 | PLK3 | 0.42241018 |
| 119 | TSSK6 | 0.41232759 |
| 120 | EGFR | 0.41074794 |
| 121 | ADRBK2 | 0.40214543 |
| 122 | CSNK2A1 | 0.40204130 |
| 123 | PRKCD | 0.39669672 |
| 124 | CHEK2 | 0.38358429 |
| 125 | TESK1 | 0.37974533 |
| 126 | PRKCQ | 0.37551185 |
| 127 | CHEK1 | 0.36945354 |
| 128 | OXSR1 | 0.36898106 |
| 129 | ABL1 | 0.35834204 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.44560634 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 2.90041220 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.53161075 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.51465095 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.36781005 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.36645582 |
| 7 | Base excision repair_Homo sapiens_hsa03410 | 2.27005968 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.25270268 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.25167889 |
| 10 | Proteasome_Homo sapiens_hsa03050 | 2.16445793 |
| 11 | Homologous recombination_Homo sapiens_hsa03440 | 2.08332306 |
| 12 | Measles_Homo sapiens_hsa05162 | 2.07507949 |
| 13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.01322877 |
| 14 | Ribosome_Homo sapiens_hsa03010 | 1.97836324 |
| 15 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.93626433 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.85695066 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.85136819 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.81944405 |
| 19 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.80198922 |
| 20 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.74051876 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.71959262 |
| 22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.67917457 |
| 23 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.62542363 |
| 24 | Cell cycle_Homo sapiens_hsa04110 | 1.58879163 |
| 25 | Legionellosis_Homo sapiens_hsa05134 | 1.58556935 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.52031264 |
| 27 | Spliceosome_Homo sapiens_hsa03040 | 1.46593185 |
| 28 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.43876729 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.43152682 |
| 30 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.42441987 |
| 31 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.41877964 |
| 32 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.40842141 |
| 33 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.39280365 |
| 34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.36815136 |
| 35 | Pertussis_Homo sapiens_hsa05133 | 1.29816572 |
| 36 | Apoptosis_Homo sapiens_hsa04210 | 1.27666796 |
| 37 | Asthma_Homo sapiens_hsa05310 | 1.26504768 |
| 38 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.25099790 |
| 39 | Malaria_Homo sapiens_hsa05144 | 1.24503216 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 1.22193683 |
| 41 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.19408010 |
| 42 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.17115069 |
| 43 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.16657212 |
| 44 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.16130868 |
| 45 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.16020319 |
| 46 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.15901368 |
| 47 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.11143197 |
| 48 | Viral myocarditis_Homo sapiens_hsa05416 | 1.08939268 |
| 49 | RNA transport_Homo sapiens_hsa03013 | 1.08900859 |
| 50 | RNA polymerase_Homo sapiens_hsa03020 | 1.05999391 |
| 51 | Hepatitis B_Homo sapiens_hsa05161 | 1.05724180 |
| 52 | Tuberculosis_Homo sapiens_hsa05152 | 1.01496496 |
| 53 | RNA degradation_Homo sapiens_hsa03018 | 0.96089639 |
| 54 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.95955757 |
| 55 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.94995610 |
| 56 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.94188389 |
| 57 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.88058920 |
| 58 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.86542931 |
| 59 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.85108610 |
| 60 | Protein export_Homo sapiens_hsa03060 | 0.84399615 |
| 61 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.83925153 |
| 62 | Parkinsons disease_Homo sapiens_hsa05012 | 0.83205200 |
| 63 | Other glycan degradation_Homo sapiens_hsa00511 | 0.83015036 |
| 64 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.81986746 |
| 65 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.81390845 |
| 66 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.81136041 |
| 67 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.79498849 |
| 68 | Salmonella infection_Homo sapiens_hsa05132 | 0.78102316 |
| 69 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.75711233 |
| 70 | Basal transcription factors_Homo sapiens_hsa03022 | 0.72884925 |
| 71 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.71659797 |
| 72 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.69508358 |
| 73 | HTLV-I infection_Homo sapiens_hsa05166 | 0.68930058 |
| 74 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.68151777 |
| 75 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.67552000 |
| 76 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.67406520 |
| 77 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.66252965 |
| 78 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.65904483 |
| 79 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.65087792 |
| 80 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.64791646 |
| 81 | Hepatitis C_Homo sapiens_hsa05160 | 0.64730301 |
| 82 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.63962001 |
| 83 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.62523285 |
| 84 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.60800024 |
| 85 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.59976426 |
| 86 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.58980766 |
| 87 | Lysosome_Homo sapiens_hsa04142 | 0.58631520 |
| 88 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.58109951 |
| 89 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.56651174 |
| 90 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.53619179 |
| 91 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.52978557 |
| 92 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.52775705 |
| 93 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.52696078 |
| 94 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.51721962 |
| 95 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50817447 |
| 96 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.49322716 |
| 97 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.49073816 |
| 98 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.48657312 |
| 99 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.48258005 |
| 100 | Phagosome_Homo sapiens_hsa04145 | 0.47206357 |
| 101 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.46407694 |
| 102 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.45613618 |
| 103 | Platelet activation_Homo sapiens_hsa04611 | 0.44587140 |
| 104 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.44506729 |
| 105 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.42638281 |
| 106 | Purine metabolism_Homo sapiens_hsa00230 | 0.42294830 |
| 107 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.41962385 |
| 108 | Huntingtons disease_Homo sapiens_hsa05016 | 0.38766014 |
| 109 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.37783258 |
| 110 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.37410957 |
| 111 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.35514130 |
| 112 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.35260603 |
| 113 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.32381613 |
| 114 | Alzheimers disease_Homo sapiens_hsa05010 | 0.31978867 |
| 115 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.31507623 |
| 116 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.31299438 |
| 117 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.31056184 |
| 118 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.31032113 |
| 119 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.30746470 |
| 120 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.30653664 |
| 121 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.30577080 |
| 122 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.20372143 |

